Stay updated on Cabozantinib vs Placebo in HCC After Sorafenib Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib vs Placebo in HCC After Sorafenib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib vs Placebo in HCC After Sorafenib Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-05-01T23:53:56.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page has undergone significant content removal, particularly regarding the details of a study on Cabozantinib (XL184) for hepatocellular carcinoma, including its purpose, study design, and inclusion/exclusion criteria. The revision number has been updated from v2.14.4 to v2.15.0.
    Difference
    13%
    Check dated 2025-04-17T11:02:12.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-10T05:40:55.000Z thumbnail image
  5. Check
    36 days ago
    No Change Detected
  6. Check
    72 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-25T19:04:55.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-11T07:28:21.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.1%
    Check dated 2025-02-04T02:56:34.000Z thumbnail image

Stay in the know with updates to Cabozantinib vs Placebo in HCC After Sorafenib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs Placebo in HCC After Sorafenib Clinical Trial page.